+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
ID05323149

Evaluating Early Use of Dexamethasone Versus Saline Placebo in Traumatic Brain Injury to Modulate Inflammation and Outcomes

Led by Assiut University · Updated on 2026-09-16

60

Participants Needed

1

Research Sites

5 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effect of Dexamethasone on inflammation in patients with traumatic brain injury TBI. This Phase 3 trial compares Dexamethasone to a saline placebo to understand its impact on inflammation and patient outcomes. The study focuses on patients with mild to moderate isolated TBI who have a Glasgow Coma Scale GCS score above 8 and who received treatment within 8 hours of injury. Participants are randomly assigned to one of two groups one receiving Dexamethasone with a loading dose of 10 mg followed by 8 mg every 6 hours for 48 hours, and the other receiving saline placebo with a similar dosing schedule. Both treatments are administered intravenously. Patients are initially assessed and managed in the emergency room, then monitored in intermediate or intensive care units during and after treatment. Throughout the study, participants undergo blood tests to measure inflammatory markers such as C-reactive protein, interleukin-6, and blood cell ratios, as well as coagulation tests. Consciousness levels are monitored using Glasgow Coma Scale, delirium is assessed with Richmond Agitation-Sedation Scale, and hemodynamics are continuously observed. Researchers track adverse effects and complications, and the primary outcome is the percentage of patients with reduced inflammation 48 hours after treatment. The trial lasts until primary completion in September 2027, with follow-up through October 2027.

CONDITIONS

Brief Title

Dexamethasone in Traumatic Brain Injury

Research Team

O

Omar Soliman

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here